The DOI matches its Crossref record; 106 of the 108 references it cites were found in a registry or an index.
Nanoparticle therapeutics: an emerging treatment modality for cancer
Abstract
Nanoparticles--particles in the size range 1-100 nm--are emerging as a class of therapeutics for cancer. Early clinical results suggest that nanoparticle therapeutics can show enhanced efficacy, while simultaneously reducing side effects, owing to properties such as more targeted localization in tumours and active cellular uptake. Here, we highlight the features of nanoparticle therapeutics that distinguish them from previous anticancer therapies, and describe how these features provide the potential for therapeutic effects that are not achievable with other modalities. While large numbers of preclinical studies have been published, the emphasis here is placed on preclinical and clinical studies that are likely to affect clinical investigations and their implications for advancing the treatment of patients with cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Using cell membranes and EVs as carriers in nanomedicine offers significant advantages, including exceptional biological compatibility, biodegradability, and a superior drug-loading performance.”
From Emerging role of exosomes in cancer therapy: progress and challenges (2025) · cites this paper as [189]
In the citing paper
“Additionally, nanopharmaceuticals derived from cell membranes and their byproducts naturally contain targeting ability, making them especially promising for the research and development of drug transport systems in lymphoma treatment.”
From Emerging role of exosomes in cancer therapy: progress and challenges (2025) · cites this paper as [189]
In the citing paper
“Immobilization of an enzyme on the surface of nanoparticles can increase enzyme stability (31), and we therefore developed DNase I-coated nanoparticles.”
From Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps (2016) · cites this paper as [31]
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Therapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,978
Self-citationMechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags
Qian, X., Peng, X.-H., Ansari, D. O., Yin-Goen, Q., Chen, G. Z., Shin, D. M., Yang, L., Young, A. N., Wang, M. D., & Nie, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1377 · Cited by 2,201
Self-citationGradishar, W. J., Tjulandin, S., Davidson, N. G. P., Shaw, H., Desai, N. P., Bhar, P., Hawkins, M., & O’Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,159
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1958 · Cited by 1,956
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature reviews. Cancer · doi:10.1038/nrc903 · Cited by 1,648
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,129
Flagged first, then by citations
2 of the 108 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Kurtzberg, J., Moore, J. O. Scudiery, D. & Franklin, A. A phase II study of polyethylene glycol (PEG) conjugated L-asparaginase in patients with refractory acute leukaemias. Proc. Am. Assoc. Cancer Res. 29, 213 (1988).
- Socinski, M. & Ramalingham, S. XYOTAX in NSCLC and other solid tumors. Emerging evidence on biological differences between men and women: is gender-specific therapy warranted? Chemotherapy Foundation web site [online], (2005).
- Vasey, P. et al. Phase I clinical and pharmacokinetic study of PKI (HPMA copolymer doxorubicin) first member of a new class of chemotherapeutics agents: drug–polymer conjugates. Clin. Cancer Res. 5, 83–94 (1999).
Cited by
Sorted by citations
Items 901–1,000 of 1,023
Photoregulated Release of Noncovalent Guests from Dendritic Amphiphilic Nanocontainers
Yesilyurt, V., Ramireddy, R. R., & Thayumanavan, S. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201006193 · Cited by 104
Drug release from core-shell PVA/silk fibroin nanoparticles fabricated by one-step electrospraying
Cao, Y., Liu, F., Chen, Y., Yu, T., Lou, D., Guo, Y., Li, P., Wang, Z., & Ran, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-12351-1 · Cited by 104
Chou, L. Y. T., & Chan, W. C. W. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200084 · Cited by 104
Multifaceted applications of bile salts in pharmacy: an emphasis on nanomedicine
Elnaggar, Y. S. R. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s82558 · Cited by 103
Li, T., Huang, C.-C., Ruan, P.-W., Chuang, K.-Y., Huang, K.-J., Shieh, D.-B., & Yeh, C. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.012 · Cited by 103
Noorani, L., Stenzel, M. H., Liang, R., Pourgholami, M. H., & Morris, D. L. (2015) · Journal of Nanobiotechnology · doi:10.1186/s12951-015-0082-8 · Cited by 103
Upconversion nanophosphors for use in bioimaging, therapy, drug delivery and bioassays
Yang, Y. (2013) · Microchimica Acta · doi:10.1007/s00604-013-1139-8 · Cited by 104
Drug delivery systems for differential release in combination therapy
Zhang, H., Wang, G., & Yang, H. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.547470 · Cited by 103
Zhang, Z., Liu, C., Bai, J., Wu, C. S., Xiao, Y., Li, Y., Zheng, J., Yang, R., & Tan, W. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b00368 · Cited by 103
He, C., Cai, P., Li, J., Zhang, T., Lin, L. Q., Abbasi, A. Z., Henderson, J. T., Rauth, A. M., & Wu, X. Y. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.12.019 · Cited by 103
Laponite-based Nanomaterials for Biomedical Applications: A Review
Das, S. S., Neelam, N., Hussain, K., Singh, S., Hussain, A., Faruk, A., & Tebyetekerwa, M. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190402165845 · Cited by 105
Gao, J., Wang, F., Wang, S., Liu, L., Liu, K., Ye, Y., Wang, Z., Wang, H., Chen, B., Jiang, J., et al. (2020) · Advanced Science · doi:10.1002/advs.201903642 · Cited by 101
Mahran, R. I., Hagras, M. M., Sun, D., & Brenner, D. E. (2016) · The AAPS Journal · doi:10.1208/s12248-016-0003-2 · Cited by 103
Bifunctional PAMAM Dendrimer Conjugates of Folic Acid and Methotrexate with Defined Ratio
Zong, H., Thomas, T. P., Lee, K.-H., Desai, A. M., Li, M.-H., Kotlyar, A., Zhang, Y., Leroueil, P. R., Gam, J. J., Holl, M. M. B., et al. (2012) · Biomacromolecules · doi:10.1021/bm201639c · Cited by 102
Translating materials design to the clinic
Hubbell, J. A., & Langer, R. (2013) · Nature Materials · doi:10.1038/nmat3788 · Cited by 102
Chen, W., Achazi, K., Schade, B., & Haag, R. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.11.012 · Cited by 102
Smart Mesoporous Nanomaterials for Antitumor Therapy
Martínez‐Carmona, M., Colilla, M., & Vallet‐Regí, M. (2015) · Nanomaterials · doi:10.3390/nano5041906 · Cited by 103
Xu, X., Li, J., Han, S., Tao, C., Fang, L., Sun, Y., Zhu, J., Liang, Z., & Li, F. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.02.015 · Cited by 102
Zhu, W., Lee, S., Castro, N. J., Yan, D., Keidar, M., & Zhang, L. G. (2016) · Scientific Reports · doi:10.1038/srep21974 · Cited by 102
Wang, Q., Gao, L., Zhu, X., Zhang, Y., Zhang, C., Xu, D. W., & Cui, Y. (2019) · Theranostics · doi:10.7150/thno.35972 · Cited by 102
Physical properties of nanoparticles do matter
Kiio, T. M., & Park, S. (2020) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-020-00504-w · Cited by 104
Homaeigohar, S., & Boccaccini, A. R. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2021.809676 · Cited by 108
Recent advances of metal-based nanoparticles in nucleic acid delivery for therapeutic applications
Sharma, A. R., Lee, Y., Bat-Ulzii, A., Bhattacharya, M., Chakraborty, C., & Lee, S. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01650-z · Cited by 110
Detoxifying Antitumoral Drugs via Nanoconjugation: The Case of Gold Nanoparticles and Cisplatin
Comenge, J., Sotelo, C. G., Romero, F. M., Gallego, O. S., Barnadas, A., Parada, T. G.-C., Domı́nguez, F., & Puntes, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047562 · Cited by 106
Application of gold nanoparticles for gastrointestinal cancer theranostics: A systematic review
Singh, M., Harris‐Birtill, D., Markar, S. R., Hanna, G. B., & Elson, D. S. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.05.010 · Cited by 107
Tamura, A., Oishi, M., & Nagasaki, Y. (2009) · Biomacromolecules · doi:10.1021/bm900252d · Cited by 101
Liang, Y., & Kiick, K. L. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.5b01541 · Cited by 102
Zhou, Y., Zhang, Q., Wang, S., Bharate, P., Varela‐Aramburu, S., Lu, M., Seeberger, P. H., & Yin, J. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201603294 · Cited by 101
Development of micro- and nanorobotics: A review
Yang, J. R., Zhang, C., Wang, X., Wang, W., Xi, N., & Liu, L. (2018) · Science China Technological Sciences · doi:10.1007/s11431-018-9339-8 · Cited by 101
Wang, Z., Chui, W., & Ho, P. C. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9837-y · Cited by 100
Nanoparticles for Targeted and Temporally Controlled Drug Delivery
Swami, A., Shi, J., Gadde, S., Votruba, A. R., Kolishetti, N., & Farokhzad, O. C. (2012) · Nanostructure science and technology · doi:10.1007/978-1-4614-2305-8_2 · Cited by 108
Reuter, K. G., Perry, J. L., Kim, D., Luft, J. C., Liu, R., & DeSimone, J. M. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b01362 · Cited by 100
Xu, J., He, F., Cheng, Z., Lv, R., Dai, Y., Gulzar, A., Liu, B., Bi, H., Yang, D., Gai, S., et al. (2017) · Chemistry of Materials · doi:10.1021/acs.chemmater.7b03461 · Cited by 100
Novel advances in targeted drug delivery
Öztürk, K., Eroğlu, H., & Çalış, S. (2017) · Journal of drug targeting · doi:10.1080/1061186x.2017.1401076 · Cited by 100
Tailoring Interfacial Nanoparticle Organization through Entropy
Zhu, G., Huang, Z., Xu, Z., & Yan, L. (2018) · Accounts of Chemical Research · doi:10.1021/acs.accounts.8b00001 · Cited by 100
The Role of Necroptosis in ROS-Mediated Cancer Therapies and Its Promising Applications
Hsu, S., Chang, W., Lin, I., Chen, Y., Padalwar, N. B., Cheng, K., Teng, Y., Wang, C., & Chiu, C. (2020) · Cancers · doi:10.3390/cancers12082185 · Cited by 102
Engineered Synthetic Polymer Nanoparticles as IgG Affinity Ligands
Lee, S.-H., Hoshino, Y., Randall, A. Z., Zeng, Z., Baldi, P., Doong, R., & Shea, K. J. (2012) · Journal of the American Chemical Society · doi:10.1021/ja303612d · Cited by 100
Nanodiamond–Mitoxantrone Complexes Enhance Drug Retention in Chemoresistant Breast Cancer Cells
Toh, T. B., Lee, D.-K., Hou, W., Abdullah, L. N., Nguyen, J., Ho, D., & Chow, E. K. (2014) · Molecular Pharmaceutics · doi:10.1021/mp5001108 · Cited by 100
Vong, L. B., Yoshitomi, T., Matsui, H., & Nagasaki, Y. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.03.037 · Cited by 100
Simultaneous RGB Emitting Au Nanoclusters in Chitosan Nanoparticles for Anticancer Gene Theranostics
Sahoo, A. K., Banerjee, S., Ghosh, S. S., & Chattopadhyay, A. (2013) · ACS Applied Materials & Interfaces · doi:10.1021/am4051266 · Cited by 100
He, M., Zhou, J., Chen, J., Zheng, F., Wang, D., Shi, R., Guo, Z. G., Wang, H., & Chen, Q. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb01830g · Cited by 98
Strategies of polymeric nanoparticles for enhanced internalization in cancer therapy
Sun, L., Wu, Q., Peng, F., Liu, L., & Gong, C. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.07.013 · Cited by 101
Liu, P., Sun, Y., Wang, Q., Sun, Y., Li, H., & Duan, Y. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.020 · Cited by 99
Chen, W., Zou, Y., Meng, F., Cheng, R., Deng, C., Feijén, J., & Zhong, Z. (2014) · Biomacromolecules · doi:10.1021/bm401749t · Cited by 99
Han, H. S., Lee, J., Kim, H. R., Chae, S. Y., Kim, M.-W., Saravanakumar, G., Yoon, H. Y., You, D. G., Ko, H., Kim, K., et al. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.02.022 · Cited by 98
Wang, X., Yang, C., Zhang, Y., Xu, Z. C., Wu, W., & Jiang, X. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.016 · Cited by 99
Pan, W., Yang, H., Zhang, T., Li, Y., Li, N., & Tang, B. (2013) · Analytical Chemistry · doi:10.1021/ac401405n · Cited by 99
Targeting diseased tissues by pHLIP insertion at low cell surface pH
Andreev, O. A., Engelman, D. M., & Reshetnyak, Y. K. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00097 · Cited by 99
The MTT and Crystal Violet Assays
Almutary, A. G., & Sanderson, B. J. S. (2016) · International Journal of Toxicology · doi:10.1177/1091581816648906 · Cited by 108
Nanoformulation-based sequential combination cancer therapy
Shim, G., Kim, M.-G., Kim, D., Park, J. Y., & Oh, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.003 · Cited by 99
Mohammed, Y. H. I., Manukumar, H. M. G., Rakesh, K. P., Karthik, C. S., Mallu, P., & Qin, H. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.07.002 · Cited by 100
Ultrafast Electrochemical Trigger Drug Delivery Mechanism for Nanographene Micromachines
Khezri, B., Beladi‐Mousavi, S. M., Krejčová, L., Heger, Z., Sofer, Z., & Pumera, M. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201806696 · Cited by 99
Two-step nanoprecipitation for the production of protein-loaded PLGA nanospheres
Morales‐Cruz, M., Flores-Fernández, G. M., Morales-Cruz, M., Orellano, E. A., Rodríguez‐Martínez, J. A., Ruiz, M., & Griebenow, K. H. (2012) · Results in Pharma Sciences · doi:10.1016/j.rinphs.2012.11.001 · Cited by 99
Enabling Cytoplasmic Delivery and Organelle Targeting by Surface Modification of Nanocarriers
Parodi, A., Corbo, C., Cevenini, A., Molinaro, R., Palomba, R., Pandolfi, L., Agostini, M., Salvatore, F., & Tasciotti, E. (2015) · Nanomedicine · doi:10.2217/nnm.15.39 · Cited by 102
Synthetic Polymer Nanoparticle–Polysaccharide Interactions: A Systematic Study
Zeng, Z., Patel, J., Lee, S.-H., McCallum, M. E., Tyagi, A., Yan, M., & Shea, K. J. (2012) · Journal of the American Chemical Society · doi:10.1021/ja209959t · Cited by 100
Zhang, Y., Teh, C., Li, M., Ang, C. Y., Tan, S. Y., Qu, Q., Korzh, V. P., & Zhao, Y. (2016) · Chemistry of Materials · doi:10.1021/acs.chemmater.6b02896 · Cited by 98
Zhou, M., Li, L., Li, L., Lin, X., Wang, F., Li, Q., & Huang, Y. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.11.005 · Cited by 99
An Updated Overview on Nanonutraceuticals: Focus on Nanoprebiotics and Nanoprobiotics
Durazzo, A., Nazhand, A., Lucarini, M., Atanasov, A. G., Souto, E. B., Novellino, E., Capasso, R., & Santini, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072285 · Cited by 105
Approved and marketed nanoparticles for disease targeting and applications in COVID-19
Abdellatif, A. A. H., & Alsowinea, A. F. (2021) · Nanotechnology Reviews · doi:10.1515/ntrev-2021-0115 · Cited by 105
Chen, Y., Chiang, C., Chen, L., Liang, P., Hsieh, W., & Lin, W.-L. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.042 · Cited by 100
Threaded macromolecules as a versatile framework for biomaterials
Tamura, A., & Yui, N. (2014) · Chemical Communications · doi:10.1039/c4cc03709j · Cited by 99
A microfluidic origami chip for synthesis of functionalized polymeric nanoparticles
Sun, J., Xianyu, Y., Li, M., Liu, W., Zhang, L., Liu, D., Liu, C., Hu, G., & Jiang, X. (2013) · Nanoscale · doi:10.1039/c3nr01289a · Cited by 98
In Vivo Nano-imaging of Membrane Dynamics in Metastatic Tumor Cells Using Quantum Dots
Gonda, K., Watanabe, T. M., Ohuchi, N., & Higuchi, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.075374 · Cited by 98
Phosphine-Gold(I) Compounds as Anticancer Agents: General Description and Mechanisms of Action
Lima, J. C., & Rodrı́guez, L. (2011) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152011797927670 · Cited by 98
Saxena, T. K., Loomis, K. H., Pai, S. B., Karumbaiah, L., Gaupp, E. A., Patil, K., Patkar, R., & Bellamkonda, R. V. (2015) · ACS Nano · doi:10.1021/nn505980z · Cited by 99
Plasma Protein Adsorption and Biological Identity of Systemically Administered Nanoparticles
Chen, D., Ganesh, S., Wang, W., & Amiji, M. M. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0178 · Cited by 102
Xue, X., Jin, S., Zhang, C., Yang, K., Huo, S., Chen, F., Zou, G., & Liang, X. (2015) · ACS Nano · doi:10.1021/nn5065452 · Cited by 98
Chen, X., Parelkar, S. S., Henchey, E., Schneider, S. S., & Emrick, T. S. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200667s · Cited by 97
Liu, J., Ma, X., Jin, S., Xue, X., Zhang, C., Wei, T., Guo, W., & Liang, X. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00311 · Cited by 98
Nanomedicines for advanced cancer treatments: Transitioning towards responsive systems
van Elk, M., Murphy, B. P., Eufrásio-da-Silva, T., O’Reilly, D. P., Vermonden, T., Hennink, W. E., Duffy, G. P., & Ruiz‐Hernández, E. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.10.013 · Cited by 100
Peng, C., Huang, Y., & Zheng, J. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.03.020 · Cited by 98
Wang, Z., Mo, H., He, Z., Chen, A., & Cheng, P. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113480 · Cited by 100
Advances in the synthesis and application of nanoparticles for drug delivery
Park, W., & Na, K. (2015) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1325 · Cited by 100
Guo, X., Qu, J., Zhu, C., Li, W., Luo, L., Yang, J., Yin, X., Li, Q., Du, Y., Chen, D., et al. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1435751 · Cited by 101
Yokoi, K., Kojic, M., Milosevic, M., Tanei, T., Ferrari, M., & Ziemys, A. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3494 · Cited by 95
Shao, Y., Shi, C., Xu, G., Guo, D., & Luo, J. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am501913m · Cited by 96
Cancer-Targeting Multifunctionalized Gold Nanoparticles in Imaging and Therapy
Jiao, P., Zhou, H., Chen, L., & Yan, B. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795656199 · Cited by 96
Pham, E., Birrer, M. J., Eliasof, S. D., Garmey, E. G., Lazarus, D. D., Lee, C. R., Man, S., Matulonis, U. A., Peters, C. G., Xu, P., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2810 · Cited by 94
Diffusion and Directionality of Charged Nanoparticles on Lipid Bilayer Membrane
Chen, P., Huang, Z., Liang, J., Cui, T., Zhang, X., Miao, B., & Yan, L. (2016) · ACS Nano · doi:10.1021/acsnano.6b07563 · Cited by 96
Theranostics Aspects of Various Nanoparticles in Veterinary Medicine
Bai, D.-P., Lin, X., Huang, Y., & Zhang, X. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113299 · Cited by 98
Drug delivery systems based on nanoparticles and related nanostructures
Vujačić, A., Bondžić, A. M., & Vasić, V. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105412 · Cited by 97
Ettadili, F. E., Aghris, S., Laghrib, F., Farahi, A., Saqrane, S., Bakasse, M., Lahrich, S., & Mhammedi, M. A. E. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.131538 · Cited by 98
Impact of Hydrophobic Sequence Patterning on the Coil-to-Globule Transition of Protein-like Polymers
Murnen, H. K., Khokhlov, A. R., Khalatur, P. G., Segalman, R. A., & Zuckermann, R. N. (2012) · Macromolecules · doi:10.1021/ma300707t · Cited by 96
Wani, A. S., Muthuswamy, E., Savithra, G. H. L., Mao, G., Brock, S. L., & Oupický, D. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0766-9 · Cited by 95
Tiloke, C., Phulukdaree, A., Anand, K., Gengan, R. M., & Chuturgoon, A. A. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25528 · Cited by 97
Mechanisms of cooperation in cancer nanomedicine: towards systems nanotechnology
Hauert, S., & Bhatia, S. N. (2014) · Trends in biotechnology · doi:10.1016/j.tibtech.2014.06.010 · Cited by 98
Ding, Y., Wang, Y., Zhou, J., Gu, X., Wang, W., Liu, C., Bao, X., Wang, C., Li, Y., & Zhang, Q. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.009 · Cited by 95
Saha, K., Bajaj, A., Duncan, B., & Rotello, V. M. (2011) · Small · doi:10.1002/smll.201100478 · Cited by 97
Shen, S., Zhang, Y., Chen, K., Luo, Y., & Wang, J. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00997 · Cited by 95
Dai, J., Song, J., Qiu, Y., Wei, J., Hong, Z., Li, L., & Yang, H. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b01307 · Cited by 95
Molinaro, R., Martinez, J. O., Zinger, A., Vita, A. D., Storci, G., Arrighetti, N., Rosa, E. D., Hartman, K. A., Basu, N., Taghipour, N., et al. (2019) · Biomaterials Science · doi:10.1039/c9bm01766f · Cited by 96
Advances in Gold Nanoparticle-Based Combined Cancer Therapy
Bromma, K., & Chithrani, D. B. (2020) · Nanomaterials · doi:10.3390/nano10091671 · Cited by 96
Shape Transformable Strategies for Drug Delivery
Jia, W., Wang, Y., Liu, R., Yu, X., & Gao, H. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202009765 · Cited by 96
Versatile carboxymethyl chitin and chitosan nanomaterials: a review
Narayanan, D., Jayakumar, R., & Chennazhi, K. P. (2014) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1301 · Cited by 95
Effect of gold nanoparticle shapes for phototherapy and drug delivery
Adnan, N. N. M., Cheng, Y., Ong, N. M. N., Kamaruddin, T. T., Rozlan, E., Schmidt, T. W., Duong, H. T. T., & Boyer, C. A. (2016) · Polymer Chemistry · doi:10.1039/c6py00465b · Cited by 95
Molecular Theranostics: A Primer for the Imaging Professional
Lee, D. Y., & Li, K. C. P. (2011) · American Journal of Roentgenology · doi:10.2214/ajr.11.6797 · Cited by 95
Oberoi, H. S., Laquer, F. C., Marky, L. A., Kabanov, A. V., & Bronich, T. K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.03.028 · Cited by 94
Tang, S., Meng, Q., Sun, H., Su, J., Yin, Q., Zhang, Z., Yu, H., Chen, L., Chen, Y., Gu, W., et al. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201601703 · Cited by 94
Red Blood Cells for Drug Delivery
Yan, J., Yu, J., Wang, C., & Gu, Z. (2017) · Small Methods · doi:10.1002/smtd.201700270 · Cited by 93
Near-Infrared Laser-Driven in Situ Self-Assembly as a General Strategy for Deep Tumor Therapy
Liu, F., Cong, Y., Qi, G., Ji, L., Qiao, Z., & Wang, H. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b03174 · Cited by 94
Metadata
- Authors
- Davis, M. E., Chen, Z., & Shin, D. M.
- Affiliations
- California Institute of Technology (US)
- Emory University (US)
- Corresponding author
- Davis, Mark E.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-09
- Volume
- 7
- Issue
- 9
- Pages
- 771-782
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2082511916
- Cited by
- 4,233
- References
- 108
- Citations by year
- 2026: 68 · 2025: 134 · 2024: 165 · 2023: 143 · 2022: 171 · 2021: 217 · 2020: 224 · 2019: 260 · 2018: 316 · 2017: 340 · 2016: 364 · 2015: 383 · 2014: 385 · 2013: 332 · 2012: 268
- FWCI
- 7.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Funders
- National Cancer Institute (U54CA119338)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Keywords
- nanotherapeutics, cancer therapy, nanomedicine, targeted drug delivery, tumor localization, cellular uptake, clinical translation, clinical trials, anticancer agents, adverse drug reactions
- MeSH terms
- Animals, Antineoplastic Agents, Clinical Trials as Topic, Drug Evaluation, Preclinical, Humans, Neoplasms, Drug Delivery Systems, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review